Application no. and date | 18715611.2 (espacenet) (Federated) (European Patent Register), 20180329 | Patent/reg. no. and date | DK/EP 3601225, 20210602 | Publication date | 20200205 | Priority no. and date | EP 17164045, 20170331 | EP pub. no. and date |
EP 3601225 20200205 | Effective date | | Applicant/owner | Janssen Pharmaceuticals, Inc., 1125 Trenton-Harbourton Road
Titusville, NJ 08560, US, Katholieke Universiteit Leuven, Waaistraat 6, bus 5105
3000 Leuven, BE | Applicant ref. no. | 1598345 | Inventor | RABOISSON, Pierre Jean-Marie Bernard, c/o Janssen Pharmaceutica NV Turnhoutseweg 30
2340 Beerse, BE, KESTELEYN, Bart Rudolf Romanie, c/o Janssen Pharmaceutica NV Turnhoutseweg 30
2340 Beerse, BE, BONFANTI, Jean-François, c/o Janssen-Cilag 1 rue Camille Desmoulins TSA 91003
92787 Issy-les-Moulineaux Cedex 9, FR, BARDIOT, Dorothée Alice Marie-Eve, c/o Cistim Leuven vzw Gaston Geenslaan 2
3001 Leuven (Heverlee), BE, MARCHAND, Arnaud Didier M, c/o Cistim Leuven vzw Gaston Geenslaan 2
3001 Leuven (Heverlee), BE | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 31/4045 (2006.01) , A61P 31/12 (2006.01) , A61P 31/14 (2006.01) , C07D 209/04 (2006.01) , C07D 209/32 (2006.01) | Title | SUBSTITUEREDE INDOLINDERIVATER SOM INHIBITORER AF DENGUEVIRUS-REPLIKATION | Int. application no. | EP2018058077 | Int. publication no. | WO2018178238 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|